Europe – Page 117 – pharmaceutical daily

February 23, 2017 Off

Novartis’s cancer drug wins FDA’s sNDA, priority review and breakthrough therapy designation

US Food and Drug Administration (FDA) has accepted Novartis’s supplemental New Drug Application (sNDA) for filing, and granted Priority Review for the expanded use of Zykadia (ceritinib) as a first-line treatment for patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.

February 22, 2017 Off

“Alarming” superbugs a risk to people, animals and food, EU warns

By Dino Mustafić

Superbug bacteria found in people, animals and food across the European Union pose an “alarming” threat to public and animal health having evolved to resist widely used antibiotics, disease and safety experts warned on Wednesday.

February 22, 2017 Off

TopiVert’s gives dry eye syndrome candidate to first patient, waits results in second half of 2017

By Dino Mustafić

A UK-based private clinical-stage biotechnology company developing Narrow Spectrum Kinase Inhibitors (NSKIs) for the treatment of chronic inflammatory gastrointestinal (GI) and ocular diseases, has triggered the phase 1/2a proof of concept study in the US of TOP1630 ophthalmic solution for the treatment of the dry eye syndrome.

February 22, 2017 Off

Verona kicks off phase two for its COPD candidate RPL544 as add-on to Spiriva

By Dino Mustafić

Verona Pharma has made an important step in the phase two clinical trial for its candidate RPL554, used for chronic obstructive pulmonary disease (COPD). Namely, the first patient has been dosed testing RPL544 as an add-on therapy to tiotropium, Spiriva.

February 22, 2017 Off

Bayer posts 10.2% net income growth

By Dino Mustafić

Bayer has reported net income of €4,531 million which is 10.2% increase comparing to 2015 (€4,110 million). The company reported earnings growth in pharmaceutical activities, while other activities remain steady.

February 22, 2017 Off

Arix Bioscience kicks off trading on London Stock Exchange

By Dino Mustafić

Arix Bioscience’s issued ordinary shares have on Wednesday been admitted to the Official List of the UK Listing Authority and to trading on the London Stock Exchange’s main market for listed securities under the ticker “ARIX”.

February 22, 2017 Off

Advanced Oncotherapy gets €30.9M deal

By Dino Mustafić

Advanced Oncotherapy, the developer of next generation proton therapy systems for cancer treatment, has secured a flexible and staged £26 million financing agreement with Bracknor Investment Group, a Dubai-based investment firm.

February 21, 2017 Off

Amgen gets more options for using Repatha, EU approves single-dosing

By Dino Mustafić

Amgen on Tuesday got clearance from the European Commission (EC) for a new single-dose delivery option for its Repatha cardiovascular drug.

February 21, 2017 Off

‘Fasting-mimicking’ diet said to reduce risk factors for aging

By Dino Mustafić

Following a diet that mimics fasting may reduce risk factors for disease in generally healthy people, according to a small study.

February 21, 2017 Off

Sobi, Valeant sign new agreement for UCDs drug distribution

By Dino Mustafić

Swedish Orphan Biovitrum (Sobi) has entered into a 3-year agreement with Ireland’s Valeant Pharmaceuticals for the distribution of Ammonul injection, an acute Urea Cycle Disorders (UCDs) drug, in Europe, the Middle East and North Africa.